Pfizer Ltd are voluntarily recalling all stock of Accupro 5mg, 10mg, 20mg, 40mg film-coated tablets as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Following testing, N-nitroso-quinapril, has been observed at a level above the acceptable limit. Nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time. The recall is at pharmacy and wholesaler level.
Further information and advice for healthcare professionals can be found on the MHRA website.